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The incidence of ﬁbroids ranges from 30% to 70% in women of reproductive age, with the peak incidence
occurring between 35 and 49 years of age. Risk factors for ﬁbroids include nulliparity, obesity, black
ethnicity, family history, polycystic ovarian syndrome, diabetes, and hypertension. Fibroids are present in
5e10% of the patients presenting with infertility. Laparoscopic myomectomy is preferred over abdominal
myomectomy because several small incisions are used rather than one larger incision. Related to the
small incisions, recuperation is usually associated with minimal discomfort. Women with infertility and
ﬁbroids become pregnant after myomectomy in approximately 50% of cases. The pregnancy rate in
patients undergoing hysteroscopic and laparoscopic/abdominal myomectomy is 45e49%. Laparoscopic
myomectomy is a technically challenging procedure with surgeon-speciﬁc limitations. Preoperative
treatments with gonadotropin-releasing hormone have been shown to reduce blood loss and shorten
operative time. The consensus states that the maximal size must be 8e10 cm and the total number of
ﬁbroids should not exceed four. It is important not to perform laparoscopic myomectomies with more
than 5e7 large ﬁbroids because in these cases, the procedure is excessively time-consuming and gives
the surgeon opportunities to miss the smaller ﬁbroids after the uterus has been incised and repaired in
too many places. The role of vasoconstrictors such as vasopressin, epinephrine, and ornipressin help with
the control of bleeding from the incised sites. Temporary clipping of the uterine artery is an effective
procedure in reducing hemoglobin loss during laparoscopic myomectomy.
Copyright  2013, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Uterine ﬁbroids (myomas) are the most common benign tumors
in women of reproductive age.1 The incidence of ﬁbroids ranges
from 30% to 70% in women of reproductive age, with the peak
incidence occurring between 35 and 49 years of age.2 Many women
are asymptomatic, therefore, a large percentage of ﬁbroids are
undiagnosed and the actual incidence is undetermined. Black
women are 3e9 times more likely to suffer from uterine ﬁbroids
compared with European ethnic groups.3 Risk factors for ﬁbroids
include nulliparity, obesity, black ethnicity, family history, polycy-
stic ovarian syndrome, diabetes, and hypertension.4 The incidence
of ﬁbroids is increased when there is a tendency to delay pregnancy
to a later age. However, uterine ﬁbroids are still detected in a small,
but signiﬁcant number of infertile women. If a causal relationshipDivision, Department of
iversity of Indonesia/Doctor
intamani Street, Number 39,
saputra).
ia-PaciﬁcAssociationforGynecologicEbetween ﬁbroids and infertility can be established, treatment is
indicated for enhancing fertility. However, the impact of ﬁbroids on
infertility is still controversial.5
Laparoscopic myomectomy was ﬁrst described in 1979, exclu-
sively for subserous ﬁbroids.5 The procedure began to be used for
intramural ﬁbroids at the beginning of the 1990s.6,7 Laparoscopic
myomectomy is preferred over abdominal myomectomy because
several small incisions are used rather than one larger incision.8
Laparoscopic surgery is usually performed for outpatient surgery
under general anesthesia. This procedure can take 1e3 hours,
depending on the size, number, and depth of the ﬁbroids within the
muscle wall of the myometrium. Patients are able to leave hospital
the same day following laparoscopic myomectomy, although a one-
night stay may be necessary. Related to the small incisions, recu-
peration is usually associated with minimal discomfort. Patients
are expected to return to normal activity within 10e14 days.9
Currently, laparoscopic myomectomy is one of the common surgi-
cal procedures for infertile patients. Despite the obvious advan-
tages of laparoscopic myomectomy, its role in the treatment of
infertility has been an issue of continuous debate.8ndoscopyandMinimally InvasiveTherapy.PublishedbyElsevierTaiwanLLC.All rightsreserved.
Fig. 1. Multiple small ﬁbroids removed by operative laparoscopy (32 myomas). Photo
by W.H.
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The relationship between infertility and uterine ﬁbroids is well
known. However, the effect of location and size of ﬁbroids on
fertility is not clear. It has been proved that the removal of sub-
mucosal ﬁbroids improves fertility, but removal of subserosal ﬁ-
broids has no impact on fertility.10,11
Fibroids are present in 5e10% of the patients presenting with
infertility; however, they are found to be the sole identiﬁed factor in
only 1e2.4% of infertile patients.12,13 Most studies give an epide-
miological estimation of the impact of ﬁbroids on infertility, for
example, one published by Buttram and Reiter.14 They have sug-
gested an association between ﬁbroids and infertility.
Women with infertility and ﬁbroids become pregnant after
myomectomy in approximately 50% of cases. Epidemiological
studies have not been able to provide deﬁnitive evidence of the
impact of ﬁbroids on fertility, therefore, a large number of studies
have been conducted based on pregnancy rates after myomec-
tomy.13 A literature review on both prospective and retrospective
studies published between 1988 and 2001 has been performed by
Donnez and Jadoul.15 The pregnancy rate in patients undergoing
hysteroscopic and laparoscopic/abdominal myomectomy was 45e
49%. More recent studies on a large series of women have conﬁrmed
these ﬁndings.16,17 During the literature review, only one compara-
tive study was found investigating the chances of pregnancy in
women undergoing laparoscopic myomectomy and in a control
group of unoperated patients. Patients with causes of infertility
other than ﬁbroids were excluded. There were 106 women who
underwent myomectomy and 106 who did not receive treatment.
The patients were followed for 9 months after allocation. A higher
delivery rate was observed in the surgical group (42% vs. 11%).18
Several hypotheses explain the mechanisms by which ﬁbroids
can lead to infertility. Fibroids can cause distortion and enlarge-
ment of the endometrial cavity by submucous and intramural
leioﬁbroids, with an intracavitary component that affects implan-
tation.19,20 Failure of implantation may also be explained by focal
endometrial vascular disturbances, endometrial inﬂammation, and
secretion of vasoactive substances.21 Leioﬁbroids may also cause
dysfunctional uterine contractility and interfere with sperm and
ovum transport. Likewise, intramural leioﬁbroids may also obstruct
the tubal ostia.22
The location of the ﬁbroid may play an important role in
determining infertility. Both large intramural and subserosal ﬁ-
broids are considered to interfere with conception and reduce the
effectiveness of the assisted reproduction cycles, whereas pedun-
culated ﬁbroids are not believed to have detrimental effects on
fertillity.23,24 The size of the ﬁbroids may represent another
important prognostic factor, with 5 cm in diameter being the size
limit that appears to justify myomectomy. In several uncontrolled
surgical trials, restoration of fertility after myomectomy has been
reported, with pregnancy rates ranging between 44% and 62%. The
time to postmyomectomy conception is short, with w80% of
pregnancies occurring during the ﬁrst year following surgery.
Therefore, myomectomy is a valuable approach for treating patients
with leioﬁbroids and otherwise unexplained infertility.25,26
Submucosal ﬁbroids are associated with a 70% reduction in
delivery rate, whereas intramural ﬁbroids have a lesser effect and
reduce the delivery rate by approximately 30%. On the contrary,
some studies have demonstrated that subserosal ﬁbroids do not
negatively affect fertility.27
Laparoscopic myomectomy in multiple ﬁbroids
Myomectomy is the surgery of choice for women who have
symptomatic ﬁbroids and who wish to retain their uterus.Laparoscopic myomectomy is preferable to the abdominal
approach in many ways, offering28,29: more rapid recovery, shorter
hospitalization, reduced blood loss, formation of fewer adhesions,
and increased pregnancy rate. Nevertheless, laparoscopic myo-
mectomy is a technically challenging procedure that requires sur-
gical skill (Fig. 1).
It is known that uterine ﬁbroids are estrogen dependent. During
pregnancy these ﬁbroids increase in size, whereas in the puerpe-
rium and menopause they shrink. Gonadotropin-releasing hor-
mone (GnRH) agonists were introduced as an efﬁcient new
treatment in certain hormone-dependent conditions. GnRH ago-
nists induce hypogonadism. This happens through pituitary
desensitization, downregulation of receptors, and inhibition of
gonadotropins. They are advantageous in the treatment of various
hormone-dependent tumors, endometriosis, and uterine ﬁbroids.30
GnRH agonists have been used in preoperative treatments to
diminish blood loss and shorten operative time. The indication
depends on the size, number, and localization of the ﬁbroids. GnRH
agonists have two preferred clinical scenarios: a uterus that ex-
tends above the umbilicus, and anemia.31 In the ﬁrst scenario, the
GnRH agonist helps to reduce the uterus to amoremanageable size.
The roles of using GnRH agonists, uterine volume, hormonal
proﬁle, and hemoglobin concentration have been monitored. In an
experiment by Golan,30 75 patients aged 34e48 years were
scheduled for surgery. The patients in the study group received two
injections of depot triptorelin (3.75 mg) at monthly intervals prior
to surgery. The author recorded the operative time, the amount of
intraoperative blood loss, and the need for blood transfusion,
duration of hospitalization, and postoperative complications. A
signiﬁcant drop in uterine volume was observed in the study group
after 2 months of preoperative treatment (32%). Compared to the
preoperative values of the control group, the hemoglobin concen-
tration increased just prior to surgery in the study group, although
the increase did not reach statistical signiﬁcance. The operative
time was signiﬁcantly shorter in the study group compared with
the control group. The intraoperative blood loss was signiﬁcantly
lower in the study group compared to the control group. Therefore,
fewer blood transfusions were needed in the study group, although
the difference could not be evaluated statistically because of the
small numbers. Hospital stay showed no difference between the
groups. The shrinkage of uterine ﬁbroids by preoperative GnRH
agonists shortened the operative time and reduced blood loss and
the need for blood transfusions. Golan30 also suggest that surgery
following triptorelin injection is smoother and has fewer post-
operative complications.
Despite its known advantages, laparoscopic myomectomy is still
a debatable operation, whose feasibility, indications, and risks are
Fig. 2. Multiple ﬁbroids removed by open laparotomy (18 myomas). Photo by W.H.
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the presence of submucous or intramural ﬁbroids that distort the
uterine cavity, ﬁbroids >3 cm, and multiple ﬁbroids. The feasibility
of laparoscopic myomectomy has been demonstrated in numerous
clinical studies. The location and size of uterine ﬁbroids are major
determinants for making a decision about which type of surgical
approach is the most feasible. The consensus states that the
maximal size must be 8e10 cm and the total number of ﬁbroids
should not exceed four.32 Some authors’ criteria for laparoscopic
myomectomy are a single intramural or subserosal ﬁbroid 15 cm
or 3 ﬁbroids of 5 cm, whereas, others believe in an individual
choice based on pathological ﬁndings and surgeon-speciﬁc limita-
tions. It is important not to perform laparoscopic myomectomies
with more than 5e7 large ﬁbroids, because in these cases, the
procedure is excessively time-consuming and the surgeon may
miss the smaller ﬁbroids after the uterus has been incised andFig. 3. Injection of vasopressin surrourepaired in too many places.33 Therefore, in such conditions, sur-
gery should be performed by open laparotomy (Fig. 2).
Dillon had used vasopressin since 1962 for open myomectomy.
It has been available in India since 2003.34 Vasopressin is a syn-
thetic antidiuretic hormone, which induces local vasoconstriction
lasting for approximately 30 minutes, and thus helps to reduce
blood loss from the incised sites.34 Vasopressin induced a
concentration-dependent increase in vessel tone. The compounds
with this slow onset of action reﬂect the time needed to cross the
cell membrane and activate intracellular calcium ions. Likewise, a
compound with fast onset (epinephrine) acts preferentially by
increasing the calcium inﬂux through receptor-operated channels.
The duration of response of vasopressin is longer than that of
epinephrine. These vasoconstrictive agents may be useful in
conjunction with gynecological endoscopic surgery.35 Vasopressin
must be used with caution for patients suffering from cardiovas-
cular diseases and hypertension because it can lead to a sudden
increase in blood pressure and precipitate angina34 (Fig. 3).
An experiment by Vercellino et al,36 there were 80 women who
underwent laparoscopic myomectomy with uterine artery tempo-
rary clipping and 86 women who received laparoscopic myomec-
tomy without clipping. The patients were followed for 3 days after
surgery. A lower median hemoglobin decrease was observed in the
patients with laparoscopic uterine artery temporary clipping and
myomectomy (1.2 g/dL vs. 1.45 g/dL). Temporary clipping of the
uterine arteries during laparoscopic myomectomy is a safe proce-
dure for controlling excessive blood loss without jeopardizing the
uterine blood supply.36,37
Fertility after myomectomy
Recent comprehensive reviews of the literature (23 studies) on
leioﬁbroids and reproduction report an overall conception rate of
57% after myomectomy among prospective studies. The conception
rate is 53e70% after myomectomy for submucous ﬁbroids and
58e65% after myomectomy with intramural or subserosal
leioﬁbroids.38nding the ﬁbroids. Photo by W.H.
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After laparoscopic myomectomy, the pregnancy rate is 54% and
comparable to that after abdominal myomectomy.39 Studies indi-
cate that laparoscopic myomectomy is a feasible choice for infertile
women. The best prognosis is found in young women with other-
wise unexplained infertility when a ﬁbroid distorts the endometrial
cavity. Laparoscopic myomectomy in infertile patients complicated
with uterine ﬁbroid is expected to improve the postoperative
pregnancy rate as observed with laparotomy. The data are not
sufﬁcient to determine whether routine vaginal delivery should be
attempted or if cesarean section is advised.40
Conclusion
Laparoscopic myomectomy provides an acceptable, and perhaps
a preferable, alternative to abdominal myomectomy for women
with symptomatic ﬁbroids who desire uterine preservation and
who have infertility primarily related to ﬁbroids. Laparoscopic
myomectomy clearly provides a faster recovery, diminished blood
loss, and decreased adhesions compared to an open approach. The
use of GnRH agonists prior to surgery improves the therapy of
multiple ﬁbroids. In multiple ﬁbroids, the maximal size must be 8e
10 cm and the total number of ﬁbroids should not exceed four
because the procedure is excessively time-consuming and the
surgeon can miss the smaller ﬁbroids after the uterus has been
incised and repaired in too many places. The role of vasoconstrictor
such as vasopressin, epinephrine, and ornipressin help in the
control of bleeding from the incised sites. Temporary clipping of the
uterine artery is an effective procedure in reducing blood loss
during laparoscopic myomectomy.
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